Position in CGC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,494
-$1,906 QoQ
Shares Held
10,005
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vestmark Advisory Solutions, Inc. holds $14,377,327 across 11 Drug Manufacturers - Specialty & Generic names. CGC ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
345,822 | $6,404,623 | |
| 2 | HLN |
Haleon plc
|
325,158 | $3,254,830 | |
| 3 | ZTS |
Zoetis Inc.
|
11,199 | $1,323,833 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
16,788 | $1,290,997 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,274 | $731,132 | |
| 6 | VTRS |
Viatris Inc
|
42,463 | $573,675 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
22,952 | $317,885 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
12,754 | $305,203 |
All Filings in CGC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,494 | 10,005 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $11,400 | 10,000 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $14,600 | 10,000 | Shares | Other | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||